2021 Volume 10 Issue 3
Creative Commons License

Spirea Plus Dietary Supplement: Formulation Development and Product Quality and Safety Testing


, , , , ,
Abstract

Good health has always been the most valuable asset as it is fundamental for survival. Various factors affect human well-being, and with our contemporary fast-paced lifestyles, the number of negative factors is increasing. Environmental hazards, physical inactivity, smoking, stress, self-medication, unhealthy eating habits are ruining our health. Recently, the attention to the importance of nutrition has intensified, as more people recognize the profound impact nutrition can make on the overall health, the quality of life, and our ability to perform everyday tasks. To help people maintain a balanced diet with a sufficient amount of vitamins, minerals, and other essential nutrients, different dietary supplements are produced. The present paper describes the dietary supplement which contains active ingredients that can effectively address metabolic disorders in lung diseases. The quality indicators, nutritional value, storage terms, and conditions are detailed. Clinical trials have been performed to evaluate the effectiveness and the functional properties of the new dietary supplement. The manufacturing process has been thoroughly examined and complies with ISO 9001, 22000, GMP to guarantee product quality and competitiveness.


How to cite this article
Vancouver
Chelnakova D, Chelnakov A, Tokhiriyon B, Poznyakovsky V, Pastushkova E, Lapina V. Spirea Plus Dietary Supplement: Formulation Development and Product Quality and Safety Testing. Int J Pharm Res Allied Sci. 2021;10(3):70-5. https://doi.org/10.51847/DhQDPJ37bU
APA
Chelnakova, D., Chelnakov, A., Tokhiriyon, B., Poznyakovsky, V., Pastushkova, E., & Lapina, V. (2021). Spirea Plus Dietary Supplement: Formulation Development and Product Quality and Safety Testing. International Journal of Pharmaceutical Research and Allied Sciences, 10(3), 70-75. https://doi.org/10.51847/DhQDPJ37bU
Issue 1 Volume 14 (2025)